Merlin Pharma Private Limited

Merlin Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH1988PTC048460 Incorporated 11 August 1988 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2024
₹16.74 Cr
▲ 24% YoY
Net profit · FY 2024
₹35.57 Lakh
Net margin 2.1%
EBITDA · FY 2024
₹56.84 Lakh
EBITDA margin 3.4%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹1.31 Cr
Issued & subscribed
Open charges
₹15.98 Cr
Satisfied ₹65.25 Lakh
Company age
38 yrs
Est. 1988
Employees · EPFO
7
Provident fund records

About Merlin Pharma Private Limited

Data last updated:

Merlin Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 August 1988 and has been in existence for over 38 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1988PTC048460. Its GSTIN is 27AAACM5135H1ZM (Maharashtra).

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹1.31 Cr. It is led by directors Sureshchand Madholal Mangal and Anoop Sureshchand Mangal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 402 Kalpataru Plaza Chincholi Bunder Rd Malad (W), Mumbai, Maharashtra, India – 400064.

As per the financials filed for FY 2024, the company reported a revenue of ₹16.74 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹35.57 Lakh (net margin 2.1%) and EBITDA of ₹56.84 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 9% over five years.

The company has about 7 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹15.98 Cr and satisfied charges of ₹65.25 Lakh on record. Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it.

Merlin Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0012818). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website merlinpharma.com.

Company details

CIN U24230MH1988PTC048460
Registration Number 048460
Incorporation Date 11 August 1988
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-18-0012818

Recognitions & Rankings of Merlin Pharma

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-18-0012818

Contact details

Merlin Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is merlinpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    402 Kalpataru Plaza Chincholi Bunder Rd Malad (W), Mumbai, Maharashtra, India – 400064
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Merlin Pharma Private Limited, buy the company report.

Comprehensive company report
Merlin Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Merlin Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Merlin Pharma Private Limited, buy the company report.

Financials of Merlin Pharma Private Limited

FY 2025 filings available

Merlin Pharma Private Limited reported revenue of ₹16.74 Cr (up 24% YoY) for FY 2024.

Revenue · FY 2024
₹16.74 Cr ▲ 24%
Net profit · FY 2024
₹35.57 Lakh margin 2.1%
EBITDA · FY 2024
₹56.84 Lakh margin 3.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 13%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 4%
5 years · compounded
▲ 4%

Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 24% growth in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹16.74 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹56.84 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹35.57 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin3.4%
Net Profit Margin2.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Merlin Pharma Private Limited, buy the company report.

Board of directors of Merlin Pharma Private Limited

Merlin Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sureshchand Madholal MangalDirector11 Aug 198838 Years 2 MonthsCurrent
Anoop Sureshchand MangalDirector20 Oct 200818 Years 0 MonthsCurrent

Peer comparison

Merlin Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Anra Pharmaceuticals Private Limited₹16.84 Cr (FY 2025)74.0%Vellaripatti, Tamil Nadu, India
MVL Medisynth Private Limited₹16.78 Cr (FY 2024)1.0%Solapur North, Maharashtra, India
Leiutis Pharmaceuticals Private Limited₹16.75 Cr (FY 2020)62.0%Hyderabad, Telangana, India
Salius Pharma Private Limited₹16.74 Cr (FY 2025)17.0%Thane, Maharashtra, India
Merlin Pharma Private Limitedthis company₹16.74 Cr (FY 2024)₹35.57 Lakh2.1%24.0%7Mumbai, Maharashtra, India
Surien Pharmaceuticals Private Limited₹16.68 Cr (FY 2025)-18.0%Chennai, Tamil Nadu, India
Oasis Laboratories Pvt Ltd₹16.68 Cr (FY 2025)-1.0%Jaipur, Rajasthan, India
Regal Healthcare Limited₹16.64 Cr (FY 2025)-15.0%Vadodara, Gujarat, India

To see the full peer comparison of Merlin Pharma Private Limited, buy the company report.

Auditor

Merlin Pharma Private Limited is audited by PRAKASH GUPTA AND CO. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
PRAKASH GUPTA AND CO.FY 20240115809W

Shareholding

The shareholding of Merlin Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Merlin Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹15.98 Cr
Satisfied charges
₹65.25 Lakh
Breakdown by lending institutions
Others₹15.98 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
15 Mar 2024100895754Others₹97.5 LakhOpen
11 Mar 2024100895746Others₹15 CrOpen
30 Aug 198990221646Central Bank of India₹6.75 LakhSatisfied
27 Apr 198990221602Central Bank of India₹58.5 LakhSatisfied

To see the full charge records of Merlin Pharma Private Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Merlin Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Merlin Pharma Private Limited has a workforce of 7 employees on its EPFO records as of Feb 28, 2025, across 1 active EPFO establishment.

Employee count
7
Active EPFO establishments
1

GST

Merlin Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAACM5135H1ZMMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Merlin Pharma Private Limited, buy the company report.

Recent activity

Merlin Pharma Private Limited has 5 board changes on record since 1988: 2 appointments and 3 cessations. The latest: Mukesh Chhitarmal Agarwal ceased to be Director on 30 May 2010.

Charges
A charge with Others of Rs. 15.00 Cr registered on 11 Mar 2024 with Charge ID 100895746 was modified on 22 Jan 2026.
AGM
Merlin Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Merlin Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 0.98 Cr with Charge ID 100895754 was registered on 15 Mar 2024.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100895746 was registered on 11 Mar 2024.
Charges
A charge registered on 30 Aug 1989 via Charge ID 90221646 with Central Bank Of India was fully satisfied on 10 Nov 2023.
Charges
A charge registered on 27 Apr 1989 via Charge ID 90221602 with Central Bank Of India was fully satisfied on 10 Nov 2023.
Ceased
Mukesh Chhitarmal Agarwal ceased to be Director.
Ceased
Aashish Suresh Mangal ceased to be Whole-Time Director.
Appointed
Anoop Sureshchand Mangal was appointed as Director.
Ceased
Anoop Sureshchand Mangal ceased to be Director.
Charges
A charge with Central Bank Of India of Rs. 0.59 Cr registered on 27 Apr 1989 with Charge ID 90221602 was modified on 27 Nov 2006.

4 earlier events are in the company report.

Frequently asked questions

Merlin Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 August 1988 (38+ years old) and is registered under CIN U24230MH1988PTC048460.

Merlin Pharma has 2 current directors:

The latest financial statements of Merlin Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Merlin Pharma is 27AAACM5135H1ZM, registered in Maharashtra.

The CIN (Corporate Identification Number) of Merlin Pharma is U24230MH1988PTC048460. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Merlin Pharma has 5 court cases on record: 1 filed by the company and 4 filed against it. Most are in the district courts.

Merlin Pharma was incorporated on 11 August 1988, making it 38+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Merlin Pharma by revenue are Anra Pharmaceuticals Private Limited, MVL Medisynth Private Limited, Leiutis Pharmaceuticals Private Limited, Salius Pharma Private Limited, Surien Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Mukesh Chhitarmal Agarwal ceased to be Director on 30 May 2010. Aashish Suresh Mangal ceased to be Whole-Time Director on 30 Mar 2009. Anoop Sureshchand Mangal was appointed as Director on 20 Oct 2008. Merlin Pharma has 5 board changes on record in total.

Yes, Merlin Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0012818).

Merlin Pharma can be reached through the website merlinpharma.com. Its registered office is in Mumbai, Maharashtra, India.